Compound details
4-Hydroxystyrene
| Compound ID | CDAMM00011 |
|---|---|
| Common name | 4-Hydroxystyrene | IUPAC name | 4-ethenylphenol |
| Molecular formula | C8H8O |
| Retention time | 9.99 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 121.064 | Theoretical mz | 121.065 |
| Error | 4.87 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.7875 |
| Inchi key | FUGYGGDSWSUORM-UHFFFAOYSA-N |
|---|---|
| Smiles | C=CC1=CC=C(C=C1)O |
| Superclass | Benzenoids |
| Class | Benzene and substituted derivatives |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P02766 | TTR | Transthyretin | T86462 | SEA |
| P05067 | APP | Beta amyloid A4 protein | T87024 | SEA |
| P16083 | NQO2 | Quinone reductase 2 | T75498 | SEA |
| P43166 | CA7 | Carbonic anhydrase VII | T37541 | SEA |
| P23280 | CA6 | Carbonic anhydrase VI | T06569 | SEA |
| Q9ULX7 | CA14 | Carbonic anhydrase XIV | T31992 | SEA |
| P80404 | ABAT | Gamma-amino-N-butyrate transaminase | T59045 | SEA |
| Q92731 | ESR2 | Estrogen receptor beta | T80896 | SEA |
| P03372 | ESR1 | Estrogen receptor alpha | T02506 | SEA |
| Q9GZQ4 | NMUR2 | Neuromedin-U receptor 2 | T04210 | SEA |
| Q16678 | CYP1B1 | Cytochrome P450 1B1 | T92521 | SEA |
| P62508 | ESRRG | Estrogen-related receptor gamma | T59875 | SEA |
| Q16236 | NFE2L2 | Nuclear factor erythroid 2-related factor 2 | T88505 | SEA |
| P51649 | ALDH5A1 | Succinate semialdehyde dehydrogenase | T13259 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T86462 | DI0026 | Amyloidosis | [ICD-11: 5D00] | P02766 | TTR |
| T87024 | DI0025 | Alzheimer disease | [ICD-11: 8A20] | P05067 | APP |
| T87024 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P05067 | APP |
| T75498 | DI0214 | Insomnia | [ICD-11: 7A00-7A0Z] | P16083 | NQO2 |
| T06569 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | P23280 | CA6 |
| T06569 | DI0372 | Seborrhoeic dermatitis | [ICD-11: EA81] | P23280 | CA6 |
| T31992 | DI0046 | Bacterial infection | [ICD-11: 1A00-1C4Z] | Q9ULX7 | CA14 |
| T31992 | DI0204 | Inborn metabolism deficiency | [ICD-11: 5C50-5C59] | Q9ULX7 | CA14 |
| T59045 | DI0060 | Brain cancer | [ICD-11: 2A00] | P80404 | ABAT |
| T59045 | DI0134 | Epilepsy/seizure | [ICD-11: 8A61-8A6Z] | P80404 | ABAT |
| T59045 | DI0135 | Epileptic encephalopathy | [ICD-11: 8A62] | P80404 | ABAT |
| T59045 | DI0266 | Mineral deficiency | [ICD-11: 5B5K] | P80404 | ABAT |
| T59045 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P80404 | ABAT |
| T80896 | DI0062 | Breast cancer | [ICD-11: 2C60-2C6Y] | Q92731 | ESR2 |
| T80896 | DI0108 | Cushing syndrome | [ICD-11: 5A70] | Q92731 | ESR2 |
| T80896 | DI0254 | Menopausal disorder | [ICD-11: GA30] | Q92731 | ESR2 |
| T80896 | DI0432 | Vasomotor/allergic rhinitis | [ICD-11: CA08] | Q92731 | ESR2 |
| T02506 | DI0106 | COVID-19 | [ICD-11: 1D6Y] | P03372 | ESR1 |
| T88505 | DI0038 | Ataxic disorder | [ICD-11: 8A03] | Q16236 | NFE2L2 |
| T13259 | DI0122 | Diagnostic imaging | [ICD-11: N.A.] | P51649 | ALDH5A1 |
| T13259 | DI0306 | Nutritional deficiency | [ICD-11: 5B50-5B71] | P51649 | ALDH5A1 |